Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-09

Clinical Trial Update: Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial compares two botulinum toxin type A products for the treatment of blepharospasm; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)
  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Blepharospasm | Phase 4 | Status: COMPLETED | Results posted: 2009-07-09